Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Obesity: A Perspective from Hypertension.

Susic D, Varagic J.

Med Clin North Am. 2017 Jan;101(1):139-157. doi: 10.1016/j.mcna.2016.08.008. Review.

PMID:
27884225
2.

Hyperuricemia: A Biomarker of Renal Hemodynamic Impairment.

Susic D, Frohlich ED.

Cardiorenal Med. 2015 Jun;5(3):175-82. doi: 10.1159/000381317. Review.

3.

Cost-effectiveness of term induction of labour using inpatient prostaglandin gel versus outpatient Foley catheter.

Austin K, Chambers GM, de Abreu Lourenco R, Madan A, Susic D, Henry A.

Aust N Z J Obstet Gynaecol. 2015 Oct;55(5):440-5. doi: 10.1111/ajo.12348. Epub 2015 Jul 14.

PMID:
26173911
4.

GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future.

Atkinson P, Koch J, Susic D, Ledger WL.

Womens Health (Lond). 2014 May;10(3):267-76. doi: 10.2217/whe.14.14. Review.

PMID:
24956293
5.

Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excess.

Susic D, Frohlich ED.

J Am Soc Hypertens. 2014 May;8(5):297-302. doi: 10.1016/j.jash.2014.02.009. Epub 2014 Feb 25.

PMID:
24726099
6.

Nebivolol prevents myocardial fibrosis and diastolic dysfunction in salt-loaded spontaneously hypertensive rats.

Susic D, Fares H, Frohlich ED.

J Am Soc Hypertens. 2012 Sep-Oct;6(5):316-23. doi: 10.1016/j.jash.2012.06.001.

PMID:
22995800
7.

Telmisartan prevents excess-salt-induced exacerbated (malignant) hypertension in spontaneously hypertensive rats.

Susic D, Fares H, Frohlich ED.

J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):126-32. doi: 10.1177/1074248412458155. Epub 2012 Aug 27.

PMID:
22927675
8.

Hypertensive Cardiovascular and Renal Disease and Target Organ Damage: Lessons from Animal Models.

Susic D, Frohlich ED.

Cardiorenal Med. 2011;1(3):139-146. doi: 10.1159/000329334. Epub 2011 Jun 25.

9.

Salt consumption and cardiovascular, renal, and hypertensive diseases: clinical and mechanistic aspects.

Susic D, Frohlich ED.

Curr Opin Lipidol. 2012 Feb;23(1):11-6. doi: 10.1097/MOL.0b013e32834d9c52. Review.

PMID:
22123673
10.

Pressure overload.

Frohlich ED, Susic D.

Heart Fail Clin. 2012 Jan;8(1):21-32. doi: 10.1016/j.hfc.2011.08.005. Review.

PMID:
22108724
11.

Sodium and its multiorgan targets.

Frohlich ED, Susic D.

Circulation. 2011 Oct 25;124(17):1882-5. doi: 10.1161/CIRCULATIONAHA.111.029371. Review. No abstract available.

PMID:
22025637
12.
13.

The ethics of obtaining consent in labour for research.

Reid R, Susic D, Pathirana S, Tracy S, Welsh AW.

Aust N Z J Obstet Gynaecol. 2011 Dec;51(6):485-92. doi: 10.1111/j.1479-828X.2011.01341.x. Epub 2011 Sep 20. Review.

PMID:
21929542
14.

Salt-induced renal injury in SHRs is mediated by AT1 receptor activation.

Susic D, Frohlich ED, Kobori H, Shao W, Seth D, Navar LG.

J Hypertens. 2011 Apr;29(4):716-23. doi: 10.1097/HJH.0b013e3283440683.

15.

Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.

Susic D, Varagic J, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1177-81. doi: 10.1152/ajpheart.00866.2009. Epub 2010 Jan 29.

16.

Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats.

Susic D, Zhou X, Frohlich ED.

Am J Nephrol. 2009;29(6):639-45. doi: 10.1159/000195633. Epub 2009 Jan 21.

PMID:
19155618
17.

Salt, arterial pressure, and cardiovascular and renal damage.

Susic D, Fares H, Frohlich ED.

Ochsner J. 2009 Winter;9(4):197-203.

18.

Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet.

Susic D, Zhou X, Frohlich ED, Lippton H, Knight M.

Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1117-H1121. doi: 10.1152/ajpheart.00055.2008. Epub 2008 Jul 11.

19.

Partial adherence to antihypertensive therapy fails to achieve full cardiovascular benefits in hypertensive rats.

Susic D, Krousel-Wood M, Zhou X, Frohlich ED.

Am J Med Sci. 2008 Jun;335(6):420-5. doi: 10.1097/MAJ.0b013e31815720a9.

PMID:
18552570
20.

Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension.

Frohlich ED, Susic D.

Curr Hypertens Rep. 2008 Apr;10(2):151-5. Review.

PMID:
18474183
21.

Coronary circulation in hypertension and aging: an experimental study.

Susic D, Varagic J, Frohlich ED.

Ochsner J. 2008 Spring;8(1):5-10.

22.

Optimal treatment of hypertension with diastolic heart failure.

Susic D, Frohlich ED.

Heart Fail Clin. 2008 Jan;4(1):117-24. doi: 10.1016/j.hfc.2007.10.002. Review.

PMID:
18313629
23.

The aging hypertensive heart: a brief update.

Susic D, Frohlich ED.

Nat Clin Pract Cardiovasc Med. 2008 Feb;5(2):104-10. doi: 10.1038/ncpcardio1091. Review.

PMID:
18223542
24.

AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure.

Varagic J, Frohlich ED, Susic D, Ahn J, Matavelli L, López B, Díez J.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H853-8. Epub 2007 Nov 30.

25.

Cross-link breakers as a new therapeutic approach to cardiovascular disease.

Susic D.

Biochem Soc Trans. 2007 Nov;35(Pt 5):853-6. Review.

PMID:
17956231
26.

Blood pressure, large arteries and atherosclerosis.

Frohlich ED, Susic D.

Adv Cardiol. 2007;44:117-124. doi: 10.1159/000096724. Review.

PMID:
17075202
27.

Cardiovascular effects of nonproteolytic activation of prorenin.

Susic D, Lippton H, Knight M, Frohlich ED.

Hypertension. 2006 Dec;48(6):e113; author reply e114. Epub 2006 Oct 16. No abstract available.

PMID:
17043161
28.

Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats.

Matavelli LC, Zhou X, Varagic J, Susic D, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H814-9. Epub 2006 Sep 22.

29.

Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR.

Susic D, Varagic J, Ahn J, Matavelli L, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H175-9. Epub 2006 Aug 11.

30.

Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR.

Varagic J, Frohlich ED, Díez J, Susic D, Ahn J, González A, López B.

Am J Physiol Heart Circ Physiol. 2006 Apr;290(4):H1503-9. Epub 2005 Nov 18.

31.

Beneficial cardiovascular actions of eplerenone in the spontaneously hypertensive rat.

Susic D, Varagic J, Ahn J, Matavelli LC, Frohlich ED.

J Cardiovasc Pharmacol Ther. 2005 Sep;10(3):197-203.

PMID:
16211209
32.

Validation of echocardiographic and Doppler indexes of left ventricular relaxation in adult hypertensive and normotensive rats.

Slama M, Ahn J, Peltier M, Maizel J, Chemla D, Varagic J, Susic D, Tribouilloy C, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1131-6. Epub 2005 Apr 29.

33.

Crosslink breakers: a new approach to cardiovascular therapy.

Susic D, Varagic J, Ahn J, Frohlich ED.

Curr Opin Cardiol. 2004 Jul;19(4):336-40. Review.

PMID:
15218393
34.
35.

Cardiac structural and functional responses to salt loading in SHR.

Ahn J, Varagic J, Slama M, Susic D, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H767-72. Epub 2004 Apr 1.

36.

Collagen cross-link breakers: a beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension.

Susic D, Varagic J, Ahn J, Frohlich ED.

Curr Drug Targets Cardiovasc Haematol Disord. 2004 Mar;4(1):97-101. Review.

PMID:
15032654
37.

Monitoring of respiratory variations of aortic blood flow velocity using esophageal Doppler.

Slama M, Masson H, Teboul JL, Arnould ML, Nait-Kaoudjt R, Colas B, Peltier M, Tribouilloy C, Susic D, Frohlich E, Andréjak M.

Intensive Care Med. 2004 Jun;30(6):1182-7. Epub 2004 Mar 5.

PMID:
15004667
38.

[Life achievements of Dr. Dusan Kentera (1925-1999). Aspects of pulmonary circulation].

Susić D.

Srp Arh Celok Lek. 2003 Mar-Apr;131(3-4):189-98. Serbian.

PMID:
14608887
39.

Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models.

Susic D, Varagic J, Ahn J, Slama M, Frohlich ED.

J Am Coll Cardiol. 2003 Sep 17;42(6):1091-7.

40.

Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age.

Slama M, Ahn J, Varagic J, Susic D, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H181-5. Epub 2003 Sep 4.

41.

Omapatrilat induces profound renal vasodilation but does not affect coronary hemodynamics.

Varagic J, Susic D, Slama M, Frohlich ED.

J Cardiovasc Pharmacol Ther. 2003 Jun;8(2):167-74.

PMID:
12808490
42.

Echocardiographic measurement of cardiac output in rats.

Slama M, Susic D, Varagic J, Ahn J, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H691-7. Epub 2002 Oct 31.

43.

Prevention of hypertension.

Slama M, Susic D, Frohlich ED.

Curr Opin Cardiol. 2002 Sep;17(5):531-6. Review.

PMID:
12357131
44.

Respiratory variations of aortic VTI: a new index of hypovolemia and fluid responsiveness.

Slama M, Masson H, Teboul JL, Arnout ML, Susic D, Frohlich E, Andrejak M.

Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1729-33. Epub 2002 Jun 20.

45.

High rate of ventricular septal defects in WKY rats.

Slama M, Susic D, Varagic J, Frohlich ED.

Hypertension. 2002 Aug;40(2):175-8.

PMID:
12154109
46.

Diastolic dysfunction in hypertension.

Slama M, Susic D, Varagic J, Frohlich ED.

Curr Opin Cardiol. 2002 Jul;17(4):368-73. Review.

PMID:
12151871
47.
48.

Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition.

Susic D, Varagic J, Frohlich ED.

Hypertension. 2001 Dec 1;38(6):1422-6.

PMID:
11751729
49.

Heart, aging, and hypertension.

Varagic J, Susic D, Frohlich E.

Curr Opin Cardiol. 2001 Nov;16(6):336-41. Review.

PMID:
11704702
50.

Low-dose ACE with alpha- or beta-adrenergic receptor inhibitors have beneficial SHR cardiovascular effects.

Varagic J, Susic D, Frohlich ED.

J Cardiovasc Pharmacol Ther. 2001 Jan;6(1):57-63.

PMID:
11452337

Supplemental Content

Support Center